Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood

Journal of Orthopaedic Research

Volumn 28, Issue 6, 2010, Pages 792-797

  Cenni, Elisabetta ^a   Avnet, Sofia ^a   Fotia, Caterina ^a,b   Salerno, Manuela ^a   Baldini, Nicola ^a,b  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Growth factor; Osteoclast; Platelet rich plasma

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; F ACTIN; GROWTH FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; BLOOD; BONE REMODELING; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINE; HUMAN; IN VITRO STUDY; OSTEOCLAST; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA;

ACID PHOSPHATASE; ACTINS; BLOOD PLATELETS; CELL DIFFERENTIATION; COLLAGEN; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOCLASTS; RANK LIGAND; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77951445405     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21073     Document Type: Article

References (21)

1. Marx RE. 2004. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:489-496.
2. Yao S, Liu D, Pan F, et al. 2006. Effect of vascular endothelial growth factor on RANK gene expression in osteoclast precursors and on osteoclastogenesis. Arch Oral Biol 51:596-602. (Pubitemid 43849636)
3. Maitz P, Kandler B, Fischer MB, et al. 2006. Activated platelets retain their potential to induce osteoclast-like cell formation in murine bone marrow cultures. Platelets 17:477-483. (Pubitemid 44665571)
4. Ogino Y, Ayukawa Y, Kukita T, et al. 2009. Platelet-rich plasma suppresses osteoclastogenesis by promoting the secretion of osteoprotegerin. J Periodontal Res 44:217-224.
5. + dendritic- like cells and inhibits macrophage maturation from human peripheral blood monocytes. J Immunol 171:669-677.
6. Rivollier A, Mazzorana M, Tebib J, et al. 2004. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104:4029-4037. (Pubitemid 39620153)
7. Granchi D, Amato I, Battistelli L, et al. 2004. In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells. Int J Cancer 111:829-838.
8. Vooijs WC, Otten HG, van Vliet M, et al. 1997. B 7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. Br J Cancer 76:1163-1169.
9. Zhang Z, Chen J, Jin D. 1998. Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: the role of receptor beta. Biochem Biophys Res Commun 251:190-194. (Pubitemid 28498084)
10. Roato I, Grano M, Brunetti G, et al. 2005. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement. FASEB J 19:228-230. (Pubitemid 40189264)
11. Vignery A. 2005. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 202:337-340. (Pubitemid 41126949)
12. Kacena MA, Nelson T, Clough ME, et al. 2006. Megakaryocyte-mediated inhibition of osteoclast development. Bone 39:991-999.
13. Pilkington MF, Sims SM, Dixon SJ. 2001. Transforming growth factor-b induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment. J Bone Miner Res 16: 1237-1247.
14. Fox SW, Lovibond AC. 2005. Current insights into the role of transforming growth factor-beta in bone resorption. Mol Cell Endocrinol 243:19-26. (Pubitemid 41572275)
15. Houde N, Chamoux E, Bisson M, et al. 2009. TGF-β1 induces human osteoclast apoptosis by upregulating bim. J Biol Chem 284:23397-23404.
16. Takai H, Kanematsu M, Yano K, et al. 1998. Transforming growth factor-β stimulates the production of osteoprotegerin/ osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273:27091-27096. (Pubitemid 28500414)
17. Shinar DM, Rodan GA. 1990. Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 126:3153-3158.
18. Hattersley G, Chambers TJ. 1991. Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function. J Bone Miner Res 6:165-172.
19. Weicht B, Maitz P, Kandler B, et al. 2007. Activated platelets positively regulate RANKL-mediated osteoclast differentiation. J Cell Biochem 102:1300-1307. (Pubitemid 350220050)
20. Dempster DW, Hughes-Begos CE, Plavetic-Chee K, et al. 2005. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J Cell Biochem 95:139-148. (Pubitemid 41420224)
21. Take I, Kobayashi Y, Yamamoto Y, et al. 2005. Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 146:5204-5214. (Pubitemid 41653034)